CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: CATHETERS MARKET, BY PRODUCT TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 Cardiovascular Catheters
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Neurovascular Catheters
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Urological Catheters
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
4.5 Intravenous Catheters
4.5.1 Key market trends, growth factors and opportunities
4.5.2 Market size and forecast, by region
4.5.3 Market analysis by country
4.6 Specialty Catheters
4.6.1 Key market trends, growth factors and opportunities
4.6.2 Market size and forecast, by region
4.6.3 Market analysis by country
CHAPTER 5: CATHETERS MARKET, BY REGION
5.1 Overview
5.1.1 Market size and forecast
5.2 North America
5.2.1 Key trends and opportunities
5.2.2 North America Market size and forecast, by Product Type
5.2.3 North America Market size and forecast, by country
5.2.3.1 U.S.
5.2.3.1.1 Market size and forecast, by Product Type
5.2.3.2 Canada
5.2.3.2.1 Market size and forecast, by Product Type
5.2.3.3 Mexico
5.2.3.3.1 Market size and forecast, by Product Type
5.3 Europe
5.3.1 Key trends and opportunities
5.3.2 Europe Market size and forecast, by Product Type
5.3.3 Europe Market size and forecast, by country
5.3.3.1 Germany
5.3.3.1.1 Market size and forecast, by Product Type
5.3.3.2 France
5.3.3.2.1 Market size and forecast, by Product Type
5.3.3.3 U.K.
5.3.3.3.1 Market size and forecast, by Product Type
5.3.3.4 Italy
5.3.3.4.1 Market size and forecast, by Product Type
5.3.3.5 Spain
5.3.3.5.1 Market size and forecast, by Product Type
5.3.3.6 Rest of Europe
5.3.3.6.1 Market size and forecast, by Product Type
5.4 Asia-Pacific
5.4.1 Key trends and opportunities
5.4.2 Asia-Pacific Market size and forecast, by Product Type
5.4.3 Asia-Pacific Market size and forecast, by country
5.4.3.1 Japan
5.4.3.1.1 Market size and forecast, by Product Type
5.4.3.2 China
5.4.3.2.1 Market size and forecast, by Product Type
5.4.3.3 India
5.4.3.3.1 Market size and forecast, by Product Type
5.4.3.4 Australia
5.4.3.4.1 Market size and forecast, by Product Type
5.4.3.5 South Korea
5.4.3.5.1 Market size and forecast, by Product Type
5.4.3.6 Rest of Asia-Pacific
5.4.3.6.1 Market size and forecast, by Product Type
5.5 LAMEA
5.5.1 Key trends and opportunities
5.5.2 LAMEA Market size and forecast, by Product Type
5.5.3 LAMEA Market size and forecast, by country
5.5.3.1 Brazil
5.5.3.1.1 Market size and forecast, by Product Type
5.5.3.2 Saudi Arabia
5.5.3.2.1 Market size and forecast, by Product Type
5.5.3.3 South Africa
5.5.3.3.1 Market size and forecast, by Product Type
5.5.3.4 Rest of LAMEA
5.5.3.4.1 Market size and forecast, by Product Type
CHAPTER 6: COMPANY LANDSCAPE
6.1. Introduction
6.2. Top winning strategies
6.3. Product Mapping of Top 10 Player
6.4. Competitive Dashboard
6.5. Competitive Heatmap
6.6. Key developments
CHAPTER 7: COMPANY PROFILES
7.1 Abbott Laboratories
7.1.1 Company overview
7.1.2 Company snapshot
7.1.3 Operating business segments
7.1.4 Product portfolio
7.1.5 Business performance
7.1.6 Key strategic moves and developments
7.2 B. Braun Melsungen AG
7.2.1 Company overview
7.2.2 Company snapshot
7.2.3 Operating business segments
7.2.4 Product portfolio
7.2.5 Business performance
7.2.6 Key strategic moves and developments
7.3 Becton, Dickinson and Company
7.3.1 Company overview
7.3.2 Company snapshot
7.3.3 Operating business segments
7.3.4 Product portfolio
7.3.5 Business performance
7.3.6 Key strategic moves and developments
7.4 Boston Scientific Corporation
7.4.1 Company overview
7.4.2 Company snapshot
7.4.3 Operating business segments
7.4.4 Product portfolio
7.4.5 Business performance
7.4.6 Key strategic moves and developments
7.5 Johnson and Johnson
7.5.1 Company overview
7.5.2 Company snapshot
7.5.3 Operating business segments
7.5.4 Product portfolio
7.5.5 Business performance
7.5.6 Key strategic moves and developments
7.6 Medtronic Plc
7.6.1 Company overview
7.6.2 Company snapshot
7.6.3 Operating business segments
7.6.4 Product portfolio
7.6.5 Business performance
7.6.6 Key strategic moves and developments
7.7 Edwards Lifesciences Corporation
7.7.1 Company overview
7.7.2 Company snapshot
7.7.3 Operating business segments
7.7.4 Product portfolio
7.7.5 Business performance
7.7.6 Key strategic moves and developments
7.8 Teleflex Incorporated
7.8.1 Company overview
7.8.2 Company snapshot
7.8.3 Operating business segments
7.8.4 Product portfolio
7.8.5 Business performance
7.8.6 Key strategic moves and developments
7.9 Cook Medical Inc.
7.9.1 Company overview
7.9.2 Company snapshot
7.9.3 Operating business segments
7.9.4 Product portfolio
7.9.5 Business performance
7.9.6 Key strategic moves and developments
7.10 Stryker Corporation
7.10.1 Company overview
7.10.2 Company snapshot
7.10.3 Operating business segments
7.10.4 Product portfolio
7.10.5 Business performance
7.10.6 Key strategic moves and developments
TABLE 1. GLOBAL CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 2. CATHETERS MARKET REVENUE, FOR CARDIOVASCULAR CATHETERS, BY REGION , 2021-2031,($MILLION)
TABLE 3. CATHETERS MARKET FOR CARDIOVASCULAR CATHETERS BY COUNTRY, 2021-2031,($MILLION)
TABLE 4. CATHETERS MARKET REVENUE, FOR NEUROVASCULAR CATHETERS, BY REGION , 2021-2031,($MILLION)
TABLE 5. CATHETERS MARKET FOR NEUROVASCULAR CATHETERS BY COUNTRY, 2021-2031,($MILLION)
TABLE 6. CATHETERS MARKET REVENUE, FOR UROLOGICAL CATHETERS, BY REGION , 2021-2031,($MILLION)
TABLE 7. CATHETERS MARKET FOR UROLOGICAL CATHETERS BY COUNTRY, 2021-2031,($MILLION)
TABLE 8. CATHETERS MARKET REVENUE, FOR INTRAVENOUS CATHETERS, BY REGION , 2021-2031,($MILLION)
TABLE 9. CATHETERS MARKET FOR INTRAVENOUS CATHETERS BY COUNTRY, 2021-2031,($MILLION)
TABLE 10. CATHETERS MARKET REVENUE, FOR SPECIALTY CATHETERS, BY REGION , 2021-2031,($MILLION)
TABLE 11. CATHETERS MARKET FOR SPECIALTY CATHETERS BY COUNTRY, 2021-2031,($MILLION)
TABLE 12. CATHETERS MARKET, BY REGION, 2021-2031,($MILLION)
TABLE 13. NORTH AMERICA CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 14. NORTH AMERICA CATHETERS MARKET, BY COUNTRY, 2021-2031,($MILLION)
TABLE 15. U.S. CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 16. CANADA CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 17. MEXICO CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 18. EUROPE CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 19. EUROPE CATHETERS MARKET, BY COUNTRY, 2021-2031,($MILLION)
TABLE 20. GERMANY CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 21. FRANCE CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 22. U.K. CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 23. ITALY CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 24. SPAIN CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 25. REST OF EUROPE CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 26. ASIA-PACIFIC CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 27. ASIA-PACIFIC CATHETERS MARKET, BY COUNTRY, 2021-2031,($MILLION)
TABLE 28. JAPAN CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 29. CHINA CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 30. INDIA CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 31. AUSTRALIA CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 32. SOUTH KOREA CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 33. REST OF ASIA-PACIFIC CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 34. LAMEA CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 35. LAMEA CATHETERS MARKET, BY COUNTRY, 2021-2031,($MILLION)
TABLE 36. BRAZIL CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 37. SAUDI ARABIA CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 38. SOUTH AFRICA CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 39. REST OF LAMEA CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 40.ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 41.ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 42.ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 43.ABBOTT LABORATORIES: NET SALES,
TABLE 44.ABBOTT LABORATORIES: KEY STRATERGIES
TABLE 45.B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
TABLE 46.B. BRAUN MELSUNGEN AG: OPERATING SEGMENTS
TABLE 47.B. BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO
TABLE 48.B. BRAUN MELSUNGEN AG: NET SALES,
TABLE 49.B. BRAUN MELSUNGEN AG: KEY STRATERGIES
TABLE 50.BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
TABLE 51.BECTON, DICKINSON AND COMPANY: OPERATING SEGMENTS
TABLE 52.BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
TABLE 53.BECTON, DICKINSON AND COMPANY: NET SALES,
TABLE 54.BECTON, DICKINSON AND COMPANY: KEY STRATERGIES
TABLE 55.BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
TABLE 56.BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
TABLE 57.BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
TABLE 58.BOSTON SCIENTIFIC CORPORATION: NET SALES,
TABLE 59.BOSTON SCIENTIFIC CORPORATION: KEY STRATERGIES
TABLE 60.JOHNSON AND JOHNSON: COMPANY SNAPSHOT
TABLE 61.JOHNSON AND JOHNSON: OPERATING SEGMENTS
TABLE 62.JOHNSON AND JOHNSON: PRODUCT PORTFOLIO
TABLE 63.JOHNSON AND JOHNSON: NET SALES,
TABLE 64.JOHNSON AND JOHNSON: KEY STRATERGIES
TABLE 65.MEDTRONIC PLC: COMPANY SNAPSHOT
TABLE 66.MEDTRONIC PLC: OPERATING SEGMENTS
TABLE 67.MEDTRONIC PLC: PRODUCT PORTFOLIO
TABLE 68.MEDTRONIC PLC: NET SALES,
TABLE 69.MEDTRONIC PLC: KEY STRATERGIES
TABLE 70.EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT
TABLE 71.EDWARDS LIFESCIENCES CORPORATION: OPERATING SEGMENTS
TABLE 72.EDWARDS LIFESCIENCES CORPORATION: PRODUCT PORTFOLIO
TABLE 73.EDWARDS LIFESCIENCES CORPORATION: NET SALES,
TABLE 74.EDWARDS LIFESCIENCES CORPORATION: KEY STRATERGIES
TABLE 75.TELEFLEX INCORPORATED: COMPANY SNAPSHOT
TABLE 76.TELEFLEX INCORPORATED: OPERATING SEGMENTS
TABLE 77.TELEFLEX INCORPORATED: PRODUCT PORTFOLIO
TABLE 78.TELEFLEX INCORPORATED: NET SALES,
TABLE 79.TELEFLEX INCORPORATED: KEY STRATERGIES
TABLE 80.COOK MEDICAL INC.: COMPANY SNAPSHOT
TABLE 81.COOK MEDICAL INC.: OPERATING SEGMENTS
TABLE 82.COOK MEDICAL INC.: PRODUCT PORTFOLIO
TABLE 83.COOK MEDICAL INC.: NET SALES,
TABLE 84.COOK MEDICAL INC.: KEY STRATERGIES
TABLE 85.STRYKER CORPORATION: COMPANY SNAPSHOT
TABLE 86.STRYKER CORPORATION: OPERATING SEGMENTS
TABLE 87.STRYKER CORPORATION: PRODUCT PORTFOLIO
TABLE 88.STRYKER CORPORATION: NET SALES,
TABLE 89.STRYKER CORPORATION: KEY STRATERGIES